No one is more qualified than you to tell lawmakers how their policies affect your ability to provide quality care and your patients’ ability to access it. Think your opinion doesn’t matter? Think again.
Several years in the making, the Key Contacts program will provide our state rheumatology societies and the ACR with the enhanced ability to more nimbly mobilize members to participate in important state legislative advocacy efforts.
As the ARHP celebrates its 50th anniversary, we want to know the one word you would use to describe our history.
In 2015, two types of symposia are offered to meeting attendees: CME-accredited and non-CME accredited.
The rapidly and constantly advancing field of rheumatology sees significant scientific breakthroughs being translated into clinical use every year.
A novel gene could become a key player in the treatment of bone loss, one of the fastest growing problems for rheumatologists. Schnurri-3 and small molecule inhibitors of the gene’s proteins could emerge as new agents to increase bone mass.
Osteoarthritis is the most common form of arthritis, but clinicians have few effective treatment options, so it’s no surprise that growing numbers of patients are using, and asking about, nutritional supplements such as glucosamine and chondroitin.
Difficult conversations fill the practice of rheumatology: Conversations about treatments, conversations with staff about office conflicts, and conversations with patients and third-party payers about finances.
Rheumatologic education is moving forward as quickly as rheumatologic treatment. With continuing funding from the Rheumatology Research Foundation, clinician educators develop a variety of new techniques to push the boundaries of medical education as they develop new techniques to collect, document, and analyze qualitative educational data.
Patients with autoimmune diseases who do not respond appropriately to treatment may be more complex than they first appear. They could also be immunodeficient.